台灣泌尿科醫學會E-School

台灣泌尿科醫學會E-School

Forecasting Bladder Voiding Function and Uroflowmetric Outcomes Based on Intravesical Prostatic Protrusion, Prostatic Dimensions, and Volume Measurements_許哲元

2024-07-08 • 觀看: 2 • 回應: 0 • 影片
New Metrics in Cancer Prognosis: A Study of Life Expectancy Impact and Healthcare Costs of Upper Tract Urothelial Carcinoma in Taiwan_胡蔚祥

2024-07-08 • 觀看: 5 • 回應: 0 • 影片
Comparative Efficacy of Cytoreductive Radical Prostatectomy Versus Systemic Treatment in Synchronous Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Study_李一宏

2024-07-08 • 觀看: 2 • 回應: 0 • 影片
Life Expectancy and Lifetime Cost for Synchronous Metastatic Prostate Cancer: Taiwan National Cohort Study in 2008-2019_劉品均

2024-07-08 • 觀看: 4 • 回應: 0 • 影片
Real-world interim outcomes of new androgen receptor pathway inhibitors (ARPi) of non-metastatic castration-resistant prostate cancer (nmCRPC) in east Asia_柯旭承

2024-07-08 • 觀看: 3 • 回應: 0 • 影片
Impact of kidney sparing surgery in UTUC treatment_王俞傑

2024-07-08 • 觀看: 5 • 回應: 0 • 影片
MRI fusion biopsy for prostate cancer detection clinical practice experience_謝博彥

2024-07-08 • 觀看: 16 • 回應: 0 • 影片
Mirabegron is better tolerated than solifenacin in Sjogren’s syndrome patients with overactive bladder symptoms_曾浩翔

2024-07-08 • 觀看: 3 • 回應: 0 • 影片
Effectiveness of Tibial Nerve Stimulation for the Treatment of OAB in Taiwanese_李定廉

2024-07-08 • 觀看: 3 • 回應: 0 • 影片
Laparoscope pectopexy for POP experience sharing_楊旻鑫

2024-07-08 • 觀看: 5 • 回應: 0 • 影片
Enfortumab vedotin real world experience from CSMUH_何承儒

2024-07-08 • 觀看: 7 • 回應: 0 • 影片
Benign Prostatic Enlargement Increases the Risk of Parkinson’s Disease: A Population-Based Study_陳建凱

2024-07-08 • 觀看: 3 • 回應: 0 • 影片

Prev
103
104
105
106
107
108
109
110
111
112
Next
/ 1052